Skip to content

The future of coeliac disease: immunology, environment and possibilities for new treatments.

The future of coeliac disease: immunology, environment and possibilities for new treatments. - CDfuture

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44841
Enrollment
400
Registered
2014-07-02
Start date
2014-07-14
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coeliac sprue Gluten intolerance

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: All children that undergo diagnostic upper gastrointestinal endoscopy under general anesthesia for medical reasons in the Willem-Alexander Children*s Hospital of the LUMC are eligible for the study. Around 120 children undergo upper gastrointestinal endoscopy in the Department of Pediatrics of the LUMC each year. They will be divided in - Cases: all children that are diagnosed with coeliac disease according to accepted criteria - Controls: all children that are diagnosed with other conditions unrelated to coeliac disease ;Informed consent and suffiecient knowledge / understanding of the Dutch language are mandatory

Exclusion criteria

Exclusion criteria: - No informed consent - Insufficient knowledge / understanding of Dutch language - Prior participation in protocol P06.140 or the present study if subject has undergone more than one endoscopy.

Design outcomes

Primary

MeasureTime frame
Definition of the disease associated T cell receptor repertoire in a large group of paediatric patients. Determination of the functional characteristics of the disease associated T cells. Correlation of the disease associated T cell receptor repertoire with disease onset and/or severity Phenotypic and functional characterisation of the intraepithelial lymphocyte compartment in patients with and without CD. Analysis of the cytokine mediated crosstalk between the lamina propria and epithelial compartments.

Secondary

MeasureTime frame
Ultimately we aim to develop novel diagnostics and preventive and therapeutic approaches for CD.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)